METABOLIC DYSFUNCTION ASSOCIATED STEATOSIC LIVER DISEASE (MASLD). UN’OTTIMA REVISIONE IN DUE PAGINE ! DA “JAMA INTERNAL MEDICINE”
A Clinical Update on MASLD Grace Y. Zhang, MD; Danielle Brandman, MD, MAS Metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease) is a growing cause of chronic liver disease, affecting 25% of the population in the US and 30% of the population globally. It is the second leading indication for liver transplant,…

